These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32317793)

  • 1. How is the risk of being diagnosed with referable diabetic retinopathy affected by failure to attend diabetes eye screening appointments?
    Virk R; Binns AM; Chambers R; Anderson J
    Eye (Lond); 2021 Feb; 35(2):477-483. PubMed ID: 32317793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme.
    Looker HC; Nyangoma SO; Cromie DT; Olson JA; Leese GP; Philip S; Black MW; Doig J; Lee N; Briggs A; Hothersall EJ; Morris AD; Lindsay RS; McKnight JA; Pearson DW; Sattar NA; Wild SH; McKeigue P; Colhoun HM;
    Diabetologia; 2013 Aug; 56(8):1716-25. PubMed ID: 23689796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis.
    Thomas RL; Dunstan F; Luzio SD; Roy Chowdury S; Hale SL; North RV; Gibbins RL; Owens DR
    BMJ; 2012 Feb; 344():e874. PubMed ID: 22362115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Progression to Referable Diabetic Eye Disease in People With Diabetes Mellitus in Auckland, New Zealand: A 12-Year Retrospective Cohort Analysis.
    Hill S; Mullins P; Murphy R; Schmiedel O; Vaghefi E; Ramke J; Squirrell D
    Asia Pac J Ophthalmol (Phila); 2021 Nov-Dec 01; 10(6):579-589. PubMed ID: 34905518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment on: How is the risk of being diagnosed with referable diabetic retinopathy affected by failure to attend diabetes eye screening appointments?
    Martins TGDS
    Eye (Lond); 2021 Jul; 35(7):2045. PubMed ID: 32572186
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors associated with non-attendance in the Irish national diabetic retinopathy screening programme (INDEAR study report no. 2).
    Kelly SR; Loiselle AR; Pandey R; Combes A; Murphy C; Kavanagh H; Fitzpatrick P; Mooney T; Kearney P; Crabb DP; Keegan DJ
    Acta Diabetol; 2021 May; 58(5):643-650. PubMed ID: 33483856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study.
    Ochs A; McGurnaghan S; Black MW; Leese GP; Philip S; Sattar N; Styles C; Wild SH; McKeigue PM; Colhoun HM;
    PLoS Med; 2019 Oct; 16(10):e1002945. PubMed ID: 31622334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-attendance at diabetic eye screening and risk of sight-threatening diabetic retinopathy: a population-based cohort study.
    Forster AS; Forbes A; Dodhia H; Connor C; Du Chemin A; Sivaprasad S; Mann S; Gulliford MC
    Diabetologia; 2013 Oct; 56(10):2187-93. PubMed ID: 23793717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. THEIA™ development, and testing of artificial intelligence-based primary triage of diabetic retinopathy screening images in New Zealand.
    Vaghefi E; Yang S; Xie L; Hill S; Schmiedel O; Murphy R; Squirrell D
    Diabet Med; 2021 Apr; 38(4):e14386. PubMed ID: 32794618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of attendance at diabetic retinopathy screening among people with type 2 diabetes: Secondary analysis of data from primary care.
    O'Keeffe D; Riordan F; Harkins V; Kearney P; Mc Hugh S
    Prim Care Diabetes; 2021 Dec; 15(6):1086-1094. PubMed ID: 34518110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of sight-threatening diabetic retinopathy in people with Type 2 diabetes mellitus and numbers needed to screen: a systematic review.
    Groeneveld Y; Tavenier D; Blom JW; Polak BCP
    Diabet Med; 2019 Oct; 36(10):1199-1208. PubMed ID: 30677170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ethnicity and other sociodemographic factors on attendance at diabetic eye screening: a 12-month retrospective cohort study.
    Olvera-Barrios A; Seltene M; Heeren TFC; Chambers R; Bolter L; Tufail A; Owen CG; Rudnicka AR; Egan C; Anderson J
    BMJ Open; 2021 Sep; 11(9):e046264. PubMed ID: 34535475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in diabetic retinopathy screening attendance and associations with vision impairment attributable to diabetes in a large nationwide cohort.
    Lawrenson JG; Bourmpaki E; Bunce C; Stratton IM; Gardner P; Anderson J;
    Diabet Med; 2021 Apr; 38(4):e14425. PubMed ID: 33064854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy.
    Scanlon PH; Aldington SJ; Stratton IM
    Diabet Med; 2014 Apr; 31(4):439-42. PubMed ID: 24093530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness.
    Tufail A; Kapetanakis VV; Salas-Vega S; Egan C; Rudisill C; Owen CG; Lee A; Louw V; Anderson J; Liew G; Bolter L; Bailey C; Sadda S; Taylor P; Rudnicka AR
    Health Technol Assess; 2016 Dec; 20(92):1-72. PubMed ID: 27981917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incentives in Diabetic Eye Assessment by Screening (IDEAS): study protocol of a three-arm randomized controlled trial using financial incentives to increase screening uptake in London.
    Judah G; Vlaev I; Gunn L; King D; King D; Valabhji J; Darzi A; Bicknell C
    BMC Ophthalmol; 2016 Mar; 16():28. PubMed ID: 26993471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age.
    Scanlon PH; Stratton IM; Bachmann MO; Jones C; Leese GP;
    Diabet Med; 2016 Dec; 33(12):1655-1658. PubMed ID: 27646856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.
    Dutra Medeiros M; Mesquita E; Gardete-Correia L; Moita J; Genro V; Papoila AL; Amaral-Turkman A; Raposo JF
    Ophthalmology; 2015 Dec; 122(12):2473-81. PubMed ID: 26383994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study.
    Bellemo V; Lim ZW; Lim G; Nguyen QD; Xie Y; Yip MYT; Hamzah H; Ho J; Lee XQ; Hsu W; Lee ML; Musonda L; Chandran M; Chipalo-Mutati G; Muma M; Tan GSW; Sivaprasad S; Menon G; Wong TY; Ting DSW
    Lancet Digit Health; 2019 May; 1(1):e35-e44. PubMed ID: 33323239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland.
    Scotland G; McKeigue P; Philip S; Leese GP; Olson JA; Looker HC; Colhoun HM; Javanbakht M
    Diabet Med; 2016 Jul; 33(7):886-95. PubMed ID: 27040994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.